580 related articles for article (PubMed ID: 29525845)
1. Anti-neutrophil cytoplasmic antibodies and their clinical significance.
Suwanchote S; Rachayon M; Rodsaward P; Wongpiyabovorn J; Deekajorndech T; Wright HL; Edwards SW; Beresford MW; Rerknimitr P; Chiewchengchol D
Clin Rheumatol; 2018 Apr; 37(4):875-884. PubMed ID: 29525845
[TBL] [Abstract][Full Text] [Related]
2. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
[TBL] [Abstract][Full Text] [Related]
3. IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
Padoan R; Gatto M; Ghirardello A; Tonello M; Franco C; Felicetti M; Schiavon F; Doria A
J Autoimmun; 2021 Nov; 124():102725. PubMed ID: 34534841
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
6. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
[TBL] [Abstract][Full Text] [Related]
7. ANCA-associated vasculitis: report from Korea.
Kim HW; Song YW
Clin Exp Nephrol; 2013 Oct; 17(5):708-711. PubMed ID: 23292177
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
10. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
11. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
[TBL] [Abstract][Full Text] [Related]
13. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
[TBL] [Abstract][Full Text] [Related]
14. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
17. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application.
Sinico RA; Radice A
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S112-7. PubMed ID: 24854381
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Diagnosis of ANCA-Associated Vasculitis (AAV) Using a Combination of Immunofluorescence Test (IIFT) and Line Immunoassay (LIA): Single-Centre Report From India.
Chauhan R; Jain D; Tiwari AK; Dorwal P; Raina V; Nandi SP
Reumatol Clin (Engl Ed); 2022 Jan; 18(1):15-19. PubMed ID: 35090607
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.
Marzano AV; Raimondo MG; Berti E; Meroni PL; Ingegnoli F
Clin Rev Allergy Immunol; 2017 Dec; 53(3):428-438. PubMed ID: 28578472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]